Federation for
Housing and

'Cities Changing Diabetes' fighting urban diabetes

Friday 23.10.2015

Urban Diabetes is an emergency in slow motion. How the ‘Cities Changing Diabetes’ initiative will fight this challenge, in a nutshell.
Nearly two-thirds of the 382 million people with diabetes live in cities. If this trend continues, as many as half a billion people will have diabetes by 2035; nearly all of them living in urban areas! 
This article by The Guardian introduces Urban Diabetes and the partner platform ‘Cities Changing Diabetes’ which pushes for urgent action on a global scale. IFHP member Novo Nordisk is one of these partners.
“The global diabetes epidemic is an emergency in slow motion,” says Lars Rebien Sørensen, chief executive officer, Novo Nordisk on the Cities Changing Diabetes website. “While there are many factors fueling the growth trajectory of diabetes, the most striking contributor is urbanisation and the growth of cities. The ‘Cities Changing Diabetes’ programme is our call to arms for people around the world to work together to tackle this for the long-term.”
The aim of the programme is to map the problem, share solutions and drive concrete action to fight the diabetes challenge in the big cities around the world. The programme is developed in partnership with University College London (UCL) and supported by Steno Diabetes Center, Denmark, as well as a range of local partners including healthcare professionals, city authorities, urban planners, businesses, academics and community leaders, amongst others.
Watch the YouTube video by Cities Changing Diabetes.